Agaricus brasiliensis KA21 May Prevent Diet-Induced Nash Through Its Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Activities in the Liver
Open Access
Abstract
Non-alcoholic steatohepatitis (NASH) is a progressive disease that occurs in the liver. As the number of people with NASH has increased, effective prevention and treatment strategies are needed. Agaricus brasiliensis KA21 (AGA) is a mushroom native to Brazil and is considered a healthy food because of its purported health benefits, including its antioxidant properties. In this study, we focused on the oxidative stress that accompanies the onset of NASH and examined whether AGA can prevent NASH development through its antioxidant activity. We used a mouse model of NASH in which pathogenesis was promoted by dietary induction. Supplementation with AGA attenuated the development of hepatic fibrosis, which is a characteristic feature of late-stage NASH. This effect appeared to be mechanistically linked to an AGA-promoted reduction in hepatic oxidative stress. These results demonstrate a novel role for AGA in NASH prevention.Keywords
Funding Information
- Japan Society for the Promotion of Science (16H05292)
This publication has 44 references indexed in Scilit:
- Antioxidant Therapy in Nonalcoholic SteatohepatitisHepatitis Research and Treatment, 2012
- Supercritical fluid extraction of Agaricus brasiliensis: Antioxidant and antimicrobial activitiesThe Journal of Supercritical Fluids, 2012
- NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic ImplicationsGut and Liver, 2012
- The MushroomAgaricus blazeiMurill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and InflammationAdvances in Pharmacological Sciences, 2011
- Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in RemissionEvidence-Based Complementary and Alternative Medicine, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human VolunteersEvidence-Based Complementary and Alternative Medicine, 2007
- The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco‐Toxicological ProblemsEvidence-Based Complementary and Alternative Medicine, 2007
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Anti-diabetic activity of β-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazeiBiotechnology Letters, 2005